Momentum Is Strong For PAVmed Inc. (NASDAQ: PAVM)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for PAVmed Inc. (PAVM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.008, or 1.63%, to $0.499. The PAVmed Inc. has recorded 108,938 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection.

Stocks Info

This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.49 and fluctuated between $0.6000 as its day high and $0.4696 as its day low. The current market capitalization of PAVmed Inc. is $58.98M. A total of 3.21 million shares were traded on the day, compared to an average of 588.88K shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, PAVM has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 3 BUYs and 0 SELLs from insiders. Insiders purchased 250,000 shares during that period but sold 0.

In the most recent transaction, Glennon Michael J bought 100,000 shares of PAVM for 0.62 per share on Dec 07. After the transaction, the Director now owns 250,000 company shares. In a previous transaction on Dec 06, Glennon Michael J bought 88,000 shares at 0.64 per share. PAVM shares that Director owns now total 150,000.

Among the insiders who bought shares, Glennon Michael J acquired of 62,000 shares on Dec 05 at a per-share price of $0.69. This resulted in the Director holding 62,000 shares of PAVM after the transaction.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for PAVM in the last 3 months, the mean price target is $2.73 with high estimates of $7.00 and low estimates of $1.00. In terms of 52-week highs and lows, PAVM has a high of $1.32 and a low of $0.21.

As of this writing, PAVM has an earnings estimate of -$0.14 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.15. The company reported an EPS of -$0.19 in the last quarter, which was 9.50% higher than expectations of -$0.21.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PAVM’s latest balance sheet shows that the firm has $77.26M in Cash & Short Term Investments as of fiscal 2021. There were $14.96M in debt and $7.56M in liabilities at the time. Its Book Value Per Share was -$0.33, while its Total Shareholder’s Equity was $79.42M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PAVM is Buy with a score of 4.00.